company background image
GTHP logo

Guided Therapeutics OTCPK:GTHP Stock Report

Last Price

US$0.13

Market Cap

US$7.7m

7D

-26.9%

1Y

-25.3%

Updated

23 Dec, 2024

Data

Company Financials

Guided Therapeutics, Inc.

OTCPK:GTHP Stock Report

Market Cap: US$7.7m

My Notes

Capture your thoughts, links and company narrative

Guided Therapeutics, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Guided Therapeutics
Historical stock prices
Current Share PriceUS$0.13
52 Week HighUS$0.23
52 Week LowUS$0.064
Beta0.52
1 Month Change-31.35%
3 Month Change-11.65%
1 Year Change-25.29%
3 Year Change-79.60%
5 Year Change-6.82%
Change since IPO-100.00%

Recent News & Updates

Recent updates

Shareholder Returns

GTHPUS Medical EquipmentUS Market
7D-26.9%-1.2%-2.7%
1Y-25.3%10.0%23.4%

Return vs Industry: GTHP underperformed the US Medical Equipment industry which returned 10% over the past year.

Return vs Market: GTHP underperformed the US Market which returned 23.4% over the past year.

Price Volatility

Is GTHP's price volatile compared to industry and market?
GTHP volatility
GTHP Average Weekly Movement30.5%
Medical Equipment Industry Average Movement7.7%
Market Average Movement6.3%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.2%

Stable Share Price: GTHP's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: GTHP's weekly volatility (31%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
19924Mark Faupelwww.guidedinc.com

Guided Therapeutics, Inc., a medical technology company, develops medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008.

Guided Therapeutics, Inc. Fundamentals Summary

How do Guided Therapeutics's earnings and revenue compare to its market cap?
GTHP fundamental statistics
Market capUS$7.75m
Earnings (TTM)-US$2.36m
Revenue (TTM)US$38.00k

203.9x

P/S Ratio

-3.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GTHP income statement (TTM)
RevenueUS$38.00k
Cost of RevenueUS$18.00k
Gross ProfitUS$20.00k
Other ExpensesUS$2.38m
Earnings-US$2.36m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.039
Gross Margin52.63%
Net Profit Margin-6,210.53%
Debt/Equity Ratio-44.0%

How did GTHP perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 16:04
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Guided Therapeutics, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Debjit ChattopadhyayEmerging Growth Equities, Ltd.